🚨 “LEARN” Claude PROPERLY.Don’t just open it and start typing. And that’s why you never unlock real leverage. In 2026, Claude mastery is not about prompts. It’s about setup systems that compound. 🎯 This is the hidden gap: Not intelligence.Not usage time.System design over 5 days. […]
Read More
Visuals turn clinical complexity into rapid understanding. Below is a compact, practical blog you can publish on your teaching site — evidence‑oriented, slide‑ready, and written for clinicians who want fast, usable methods to convert psychiatric text into clear graphics. Start with one short paragraph (purpose). Visual […]
Read MoreSumming up, “How to Learn Anything Faster (Simple Study Guide for Students)” emphasizes that effective learning is about studying “smart,” not necessarily studying longer. It outlines six key techniques: The post concludes by encouraging readers to apply these techniques consistently for improved academic performance.
Read More
What is Metabolic Psychiatry? Metabolic psychiatry is an emerging medical subspecialty that focuses on the profound connection between metabolic health and brain function. It operates on the principle that many mental health disorders—such as depression, bipolar disorder, and schizophrenia—are not just “chemical imbalances” but are closely tied to […]
Read More
The Art and Science of Coming Off—and Staying Off—Psychiatric Drugs by Danish clinical psychologist and researcher Anders Sørensen, PhD. Summary of “Crossing Zero” The core thesis of Crossing Zero is that psychiatric deprescribing (tapering off psychiatric medications) is not merely a biological process of dose reduction but a profound […]
Read More
Scattered Minds: The Origins and Healing of Attention Deficit Disorder, by renowned physician Dr. Gabor Mate . Core Thesis: A Shift in Perspective In Scattered Minds, Dr. Gabor Maté—who has been diagnosed with ADHD himself—challenges the traditional medical model. He argues that Attention Deficit Disorder (ADD/ADHD) is not a purely genetic, […]
Read More
KarXT (Cobenfy – xanomeline/trospium chloride) is not merely a new antipsychotic; it represents the first mechanistic breakthrough in schizophrenia pharmacotherapy in over 70 years. Its arrival marks a paradigm shift from the dopamine-centric model that has defined antipsychotic treatment since chlorpromazine. The Revolutionary Mechanism KarXT is […]
Read More
The Biggest Story — KarXT (Cobenfy®): The First Non-Dopaminergic Antipsychotic September 2024: A Historic FDA Approval Background: The KarXT Revolution: What Is It? The Ingenious Solution: Phase 3 EMERGENT Trial Results: Real-World Data (2025-2026): December 2024 — Cognitive Improvement Confirmed: Current Studies (2026): Iclepertin Failure — […]
Read More
A Comprehensive Review Presentation for Psychiatrists PART ONE: AI Impact AND SCHIZOPHRENIA SLIDE 1: Overview — Why AI Matters in Schizophrenia The Clinical Challenge Schizophrenia affects ~21 million people worldwide and is characterized by: The AI Promise “With the rapid advancement of machine learning and deep […]
Read More
1. THE NARCOLEPSY SPECTRUM: Updated Understanding Beyond the Classic Tetrad A diagnosis of narcolepsy may be delayed because of its broad symptom presentation, which is much more encompassing than the classical “tetrad” of sleepiness, cataplexy, hallucinations, and sleep paralysis. Furthermore, symptoms can vary over time, and […]
Read More
